Neuromuscular disorders in zebrafish: State of the art and future perspectives

NeuroMolecular Medicine

Volumn 15, Issue 2, 2013, Pages 405-419

  Pappalardo, Andrea ^a   Pitto, Letizia ^b   Fiorillo, Chiara ^a   Alice Donati, M ^c   Bruno, Claudio ^d   Santorelli, Filippo M ^a  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Pediatric Neurology Unit   (Italy)

Author keywords

Animal model; Neuromuscular disorders; Pathogenesis; Zebrafish

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; DOCKING 7 PROTEIN; DOCKING PROTEIN; DYSFERLIN; DYSTROGLYCAN; PHOSPHODIESTERASE V INHIBITOR; PROGRANULIN; RAPSYN; SILDENAFIL; SURVIVAL MOTOR NEURON PROTEIN 1; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

CONGENITAL MYASTHENIC SYNDROME; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; GENE DELETION; GENE MUTATION; GENETIC MANIPULATION; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MYOCLONUS EPILEPSY; NERVE DEGENERATION; NEUROMUSCULAR DISEASE; NEUROMUSCULAR JUNCTION DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY; TRANSGENICS; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; FORECASTING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; GENETIC TECHNIQUES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MUSCULAR ATROPHY, SPINAL; MUSCULAR DYSTROPHY, ANIMAL; NERVE TISSUE PROTEINS; NEUROMUSCULAR DISEASES; SEQUENCE ANALYSIS, DNA; ZEBRAFISH; ZEBRAFISH PROTEINS;

ANIMALIA; DANIO RERIO;

EID: 84877758433     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-013-8228-z     Document Type: Review

References (138)

1. Adamo, C. M.; Dai, D. F.; Percival, J. M.; Minami, E.; Willis, M. S.; Patrucco, E.; et al. (2010). Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America, 107, 19079-19083.
2. Amato, A.; & Russell, J. (2008). Neuromuscular disorders. New York: McGraw-Hill Co. Inc.
3. Amato, V.; Vina, E.; Calavia, M. G.; Guerriera, M. C.; Laurà, R.; Navarro, M.; et al. (2012). TRPV4 in the sensory organs of Adult Zebrafish. Microscopy Research and Technique, 75, 89-96.
4. Aravind, L.; & Koonin, E. V. (1999). The fukutin protein family-predicted enzymes modifying cell-surface molecules. Current Biology, 9, 836-837.
5. Assereto, S.; Stringara, S.; Sotgia, F.; Bonuccelli, G.; Broccolini, A.; Pedemonte, M.; et al. (2006). Pharmacological rescue of the dystrophin- glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment. American Journal of Physiology Cell Physiology, 290, C577-C582.
6. Auer-Grumbach, M.; Olschewski, A.; Papic, L.; Kremer, H.; McEntagart, M. E.; Uhrig, S.; et al. (2010). Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nature Genetics, 42, 160-164.
7. Avşar-Ban, E.; Ishikawa, H.; Manya, H.; Watanabe, M.; Akiyama, S.; Miyake, H.; et al. (2010). Protein O-mannosylation is necessary for normal embryonic development in zebrafish. Glycobiology, 20, 1089-1102.
8. Bai, X. H.; Wang, D. W.; Kong, L.; Zhang, Y.; Luan, Y.; Kobayashi, T.; et al. (2009). ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor. Molecular and Cellular Biology, 29, 4201-4219.
9. Bang, M. L.; Centner, T.; Fornoff, F.; Geach, A. J.; Gotthardt, M.; McNabb, M.; et al. (2001). The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circulation Research, 89, 1065-1072.
10. Bansal, D.; Miyake, K.; Vogel, S. S.; Groh, S.; Chen, C. C.; Williamson, R.; et al. (2003). Defective membrane repair in dysferlin deficient muscular dystrophy. Nature, 423, 168-172.
11. Barišić, N.; Chaouch, A.; Müller, J. S.; Lochmüller, H. (2011). Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes. European Journal of Paediatric Neurology, 15, 189-196
12. Barone, R.; Aiello, C.; Race, V.; Morava, E.; Foulquier, F.; Riemersma, M.; et al. (2012). DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy. Annals of Neurology, 72, 550-558.
13. Bashir, R.; Britton, S.; Strachan, T.; Keers, S.; Vafiadaki, E.; Lako, M.; et al. (1998). A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genetics, 20, 37-42.
14. Bassett, D. I.; Bryson-Richardson, R. J.; Daggett, D. F.; Gautier, P.; Keenan, D. G.; & Currie, P. D. (2003). Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development, 130, 5851-5860.
15. Bassett, D.; & Currie, P. D. (2004). Identification of a zebrafish model of muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, 31, 537-540.
16. Bateman, A.; & Bennett, H. P. (2009). The granulin gene family: From cancer to dementia. BioEssays, 31, 1245-1254.
17. Beattie, C. E.; Carrel, T. L.; & McWhorter, M. L. (2007). Fishing for a mechanism: Using zebrafish to understand spinal muscular atrophy. Journal of Child Neurology, 22, 995-1003.
18. Belkin, A. M.; & Stepp, M. A. (2000). Integrins as receptor for laminins. Microscopy Research and Technique, 51(3), 280-301.
19. Bello, L.; Melacini, P.; Pezzani, R.; D'Amico, A.; Piva, L.; Leopardi, E.; et al. (2012). Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. European Journal of Human Genetics, 20, 1234-1239.
20. Beltran-Valero de Bernabé, D.; Currier, S.; Steinbrecher, A.; Celli, J.; van Beusekom, E.; van der Zwaag, B.; et al. (2002). Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. American Journal of Human Genetics, 7, 1033-1043.
21. Bhandari, V.; Palfree, R. G.; & Bateman, A. (1992). Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proceedings of the National Academy of Sciences of the United States of America, 89, 1715-1719.
22. Biancheri, R.; Falace, A.; Tessa, A.; Pedemonte, M.; Scapolan, S.; Cassandrini, D.; et al. (2007). POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changes. Biochemical and Biophysical Research Communications, 363, 1033-1037.
23. Boch, J.; Scholze, H.; Schornack, S.; Landgraf, A.; Hahn, S.; Kay, S.; et al. (2009). Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 326, 1509-1512.
24. Bolanos-Jimenez, F.; Bordais, A.; Behra, M.; Strahle, U.; Mornet, D.; Sahel, J.; et al. (2001). Molecular cloning and characterization of dystrophin and Dp71, two products of the Duchenne Muscular Dystrophy gene, in zebrafish. Gene, 274, 217-226.
25. Bonuccelli, G.; Sotgia, F.; Schubert, W.; Park, D. S.; Frank, P. G.; Woodman, S. E.; et al. (2003). Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. American Journal of Pathology, 163, 1663-1675.
26. Boon, K. L.; Xiao, S.; McWhorter, M. L.; Donn, T.; Wolf-Saxon, E.; Bohnsack, M. T.; et al. (2009). Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Human Molecular Genetics, 18, 3615-3625.
27. Brockington, M.; Yuva, Y.; Prandini, P.; Brown, S. C.; Torelli, S.; Benson, M. A.; et al. (2001). Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Human Molecular Genetics, 10, 2851-2859.
28. Brown, S. C.; & Winder, S. J. (2012). Dystroglycan and dystroglycanopathies: report of the 187th ENMC Workshop 11-13 November 2011, Naarden, The Netherlands. Neuromuscular Disorders, 22, 659-668.
29. Brzustowicz, L. M.; Lehner, T.; Castilla, L. H.; Penchaszadeh, G. K.; Wilhelmsen, K. C.; Daniels, R.; et al. (1990). Genetic mapping of chronic childhood onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature, 344, 540-541.
30. Cade, L.; Reyon, D.; Hwang, W. Y.; Tsai, S. Q.; Patel, S.; Khayter, C.; et al. (2012). Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Research, 40, 8001-8010.
31. Carrel, T. L.; McWhorter, M. L.; Workman, E.; Zhang, H.; Wolstencroft, E. C.; Lorson, C.; et al. (2006). Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J of Neuroscience, 26, 11014-11022.
32. Chambers, S. P.; Dodd, A.; Overall, R.; Sirey, T.; Lam, L. T.; Morris, G. E.; et al. (2001). Dystrophin in adult zebrafish muscle. Biochemical and Biophysical Research Communications, 286, 478-483.
33. Cheng, L.; Guo, X.; Yang, X.; Chong, M.; Cheng, J.; Li, G.; et al. (2006). Delta-sarcoglycan is necessary for early heart and muscle development in zebrafish. Biochemical and Biophysical Research Communications, 344, 1290-1299.
34. Chitramuthu, B. P.; Baranowski, D. C.; Kay, D. G.; Bateman, A.; & Bennett, H. P. J. (2010). Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Molecular Neurodegeneration, 5, 41.
35. Clark, K. J.; Voytas, D. F.; & Ekker, S. C. (2011). A TALE of two nucleases: Gene targeting for the masses? Zebrafish, 8, 147-149.
36. Damann, N.; Voets, T.; & Nilius, B. (2008). TRPs in our senses. Current Biology, 18, R880-R889.
37. Daniel, R.; Daniels, E.; He, Z.; & Bateman, A. (2003). Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Developmental Dynamics, 227, 593-599.
38. Desmarais, J. A.; Cao, M.; Bateman, A.; & Murphy, B. D. (2008). Spatiotemporal expression pattern of progranulin in embryo implantation and placenta formation suggests a role in cell proliferation, remodeling, and angiogenesis. Reproduction, 136, 247-257.
39. Detrich, H. W.; 3rd, Westerfield, M.; & Zon, L. I. (2011). The zebrafish. Preface. Methods Cell Biology, 105, 3-5.
40. Diaz-Cueto, L.; & Gerton, G. L. (2001). The influence of growth factors on the development of preimplantation mammalian embryos. Archives of Medical Research, 32, 619-626.
41. Durbeej, M.; & Campbell, K. P. (2002). Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models. Current Opinion in Genetics and Development, 12, 349-361.
42. Emery, A. E. (1991). Population frequencies of inherited neuromuscular diseases: A world survey. Neuromuscular Disorders, 1, 19-29.
43. Engel, A. G. (2012). Congenital myasthenic syndromes in 2012. Current Neurology and Neuroscience Reports, 12, 92-101.
44. Engel, A. G.; & Sine, S. M. (2005). Current understanding of congenital myasthenic syndromes. Current Opinion in Pharmacology, 5, 308-321.
45. Esapa, C. T.; Benson, M. A.; Schroder, J. E.; Martin-Rendon, E.; Brockington, M.; Brown, S. C.; et al. (2002). Functional requirements for fukutin related protein in the Golgi apparatus. Human Molecular Genetics, 11, 3319-3331.
46. Finlayson, S.; Beeson, D.; & Palace, J. (2013). Congenital myasthenic syndromes: An update. Practical Neurology, 13, 80-91.
47. Fiorillo, C.; Moro, F.; Brisca, G.; Astrea, G.; Nesti, C.; Bálint, Z.; et al. (2012). TRPV4 mutations in children with congenital distal spinal muscular atrophy. Neurogenetics, 13(3), 195-203.
48. Froehner, S. C.; Gulbrandsen, V.; Hyman, C.; Jeng, A. Y.; Neubig, R. R.; & Cohen, J. B. (1981). Immunofluorescence localization at the mammalian neuromuscular junction of the Mr 43,000 protein of Torpedo postsynaptic membranes. Proceedings of the National Academy of Sciences of the United States of America, 78, 5230-5234.
49. Gautam, M.; Noakes, P. G.; Mudd, J.; Nichol, M.; Chu, G. C.; Sanes, J. R.; et al. (1995). Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature, 377, 232-236.
50. Godfrey, C.; Escolar, D.; Brockington, M.; Clement, E. M.; Mein, R.; Jimenez-Mallebrera, C.; et al. (2006). Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Annals of Neurology, 60, 603-610.
51. Godfrey, C.; Foley, A. R.; Clement, E.; & Muntoni, F. (2011). Dystroglycanopathies: Coming into focus. Current Opinion in Genetics and Development, 21, 278-285.
52. Granato, M.; van Eeden, J. M. F.; Schach, U.; Trowe, T.; Brand, M.; Furutani-Seiki, M.; et al. (1996). Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development, 123, 399-413.
53. Grewal, P. K.; & Hewitt, J. E. (2002). Mutation of large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochimica et Biophysica Acta, 1573, 216-224.
54. Grewal, P. K.; Holzfeind, P. J.; Bittner, R. E.; & Hewitt, J. E. (2001). Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nature Genetics, 28, 151-154.
55. Grewal, P. K.; McLaughlan, J. M.; Moore, C. J.; Browning, C. A.; & Hewitt, J. E. (2005). Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology, 15, 912-923.
56. Grounds, M.; Sorokin, L.; & White, J. (2005). Strength at the extracellular matrix-muscle interface. Scandinavian Journal of Medicine and Science in Sports, 15(6), 381-391.
57. Gupta, V.; Kawahara, G.; Gundry, S. R.; Chen, A. T.; Lencer, W. I.; Zhou, Y.; et al. (2011). The zebrafish dag1 mutant: A novel genetic model for dystroglycanopathies. Human Molecular Genetics, 20, 1712-1725.
58. Guyon, J. R.; Goswami, J.; Jun, S. J.; Thorne, M.; Howell, M.; Pusack, T.; et al. (2009). Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin. Human Molecular Genetics, 18, 202-211.
59. Guyon, J. R.; Mosley, A. N.; Jun, S. J.; Montanaro, F.; Steffen, L. S.; Zhou, Y.; et al. (2005). Delta-sarcoglycan is required for early zebrafish muscle organization. Experimental Cell Research, 304, 105-115.
60. Guyon, J. R.; Mosley, A. N.; Zhou, Y.; Davidson, A. J.; Sheng, X.; Chiang, K.; et al. (2003). The dystrophin associated protein complex in zebrafish. Human Molecular Genetics, 12, 601-615.
61. Hackman, P.; Vihola, A.; Haravuori, H.; Marchand, S.; Sarparanta, J.; De Seze, J.; et al. (2002). Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. American Journal of Human Genetics, 71, 492-500.
62. Hall, T. E.; Bryson-Richardson, R. J.; Berger, S.; Jacoby, A. S.; Cole, N. J.; Hollway, G. E.; et al. (2007). The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America, 104, 7092-7097.
63. Hans, S.; Freudenreich, D.; Geffarth, M.; Kaslin, J.; Machate, A.; & Brand, M. (2011). Generation of a non-leaky heat shock-inducible Cre line for conditional Cre/lox strategies in zebrafish. Developmental Dynamics, 240, 108-115.
64. Hao, L. T.; Burghes, A. H. M.; & Beattie, E. C. (2011). Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene. Molecular Neurodegeneration, 6, 24.
65. Hao, L. T.; Wolman, M.; Granato, M.; & Beattie, C. E. (2012). Survival Motor Neuron affects Plastin 3 protein levels leading to motor defects. Journal of Neuroscience, 32, 5074-5084.
66. Haravuori, H.; Vihola, A.; Straub, V.; Auranen, M.; Richard, I.; Marchand, S.; et al. (2001). Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene. Neurology, 56, 869-877.
67. Harvey, A. R.; & Fletcher-Holmes, D. W. (2004). Birefringent Fourier-transform imaging spectrometer. Optics Express, 12, 5368-5374.
68. He, Z.; Ong, C. H.; Halper, J.; & Bateman, A. (2003). Progranulin is a mediator of the wound response. Nature Medicine, 9, 225-229.
69. Helbling-Leclerc, A.; Zhang, X.; Topaloglu, H.; Cruaud, C.; Tesson, F.; Weissenbach, J.; et al. (1995). Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genetics, 11, 216-218.
70. Hewitt, J. E. (2009). Abnormal glycosylation of dystroglycan in human genetic disease. Biochimica et Biophysica Acta, 1792, 853-861.
71. Holt, K. H.; Crosbie, R. H.; Venzke, D. P.; & Campbell, K. P. (2000). Biosynthesis of dystroglycan: Processing of a precursor propeptide. FEBS Letters, 468, 79-83.
72. Illa, I.; Serrano-Munuera, C.; Gallardo, E.; Lasa, A.; Rojas-García, R.; Palmer, J.; et al. (2001). Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype. Annals of Neurology, 49, 130-134.
73. Joung, J. K.; & Sander, J. D. (2013). TALENs: A widely applicable technology for targeted genome editing. Nature Reviews, 14, 49-55.
74. Kabashi, E.; Brustein, E.; Champagne, N.; & Drapeau, P. (2011). Zebrafish models for the functional genomics of neurogenetic disorders. Biochimica et Biophysica Acta, 1812, 335-345.
75. Kabashi, E.; Champagne, N.; Brustein, E.; & Drapeau, P. (2010). In the swim of things: Recent insights to neurogenetic disorders from zebrafish. Trends in Genetics, 26, 373-381.
76. Kaplan, J. C.; & Hamroun, D. (2012). The 2013 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscular Disorders, 22(12), 1108-1135.
77. Kawahara, G.; Guyon, J. R.; Nakamura, Y.; & Kunkel, L. M. (2010). Zebrafish models for human FKRP muscular dystrophies. Human Molecular Genetics, 19, 623-633.
78. Kawahara, G.; Karpf, J. A.; Myers, J. A.; Alexander, M. S.; Guyon, J. R.; & Kunkel, L. M. (2011a). Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America, 108, 5331-5336.
79. Kawahara, G.; Serafini, P. R.; Myers, J. A.; Alexander, M. S.; & Kunkel, L. M. (2011b). Characterization of zebrafish dysferlin by morpholino knockdown. Biochemical and Biophysical Research Communications, 413, 358-363.
80. Kessenbrock, K.; Frohlich, L.; Sixt, M.; Lammermann, T.; Pfister, H.; Bateman, A.; et al. (2008). Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. Journal of Clinical Investigation, 118, 2438-2447.
81. Kliegman, R. M.; Behrman, R. E.; Jenson, H. B.; & Stanton, B. F. (2007) Muscular dystrophies. In: Nelson textbook of pediatrics (18th Ed). Philadelphia: Saunders Elsevier, Chap. 608.
82. Kobayashi, K.; Nakahori, Y.; Miyake, M.; Matsumura, K.; Kondo-Iida, E.; Nomura, Y.; et al. (1998). An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature, 394, 388-392.
83. LaRochelle, W. J.; & Froehner, S. C. (1986). Determination of the tissue distributions and relative concentrations of the postsynaptic 43 kDa protein and the acetylcholine receptor in Torpedo. Journal of Biological Chemistry, 261, 5270-5274.
84. Lefeber, D. J.; Schönberger, J.; Morava, E.; Guillard, M.; Huyben, K. M.; Verrijp, K.; et al. (2011). Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies. Human Molecular Genetics, 20, 1763-1775.
85. Leong, I. U.; Lai, D.; Lan, C. C.; Johnson, R.; Love, D. R.; Johnson, R.; et al. (2011). Targeted mutagenesis of zebrafish: use of zinc finger nucleases. Birth Defects Research. Part C, Embryo Today, 93, 249-255.
86. Lin, Y. Y. (2012). Muscle diseases in the zebrafish. Neuromuscular Disorders, 22, 673-684.
87. Liu, J.; Aoki, M.; Illa, I.; Wu, C.; Fardeau, M.; Angelini, C.; et al. (1998). Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genetics, 20, 31-36.
88. Longman, C.; Brockington, M.; Torelli, S.; Jimenez-Mallebrera, C.; Kennedy, C.; Khalil, N.; et al. (2003). Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Human Molecular Genetics, 12, 2853-2861.
89. Maeda, Y.; van den Heuve, L.; Lammens, M.; Lehle, L.; & Wevers, R. A. (2009). Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. American Journal of Human Genetics, 85, 76-86.
90. Manya, H.; Chiba, A.; Yoshida, A.; Wang, X.; Chiba, Y.; Jigami, Y.; et al. (2004). Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proceedings of the National Academy of Sciences of the United States of America, 101, 500-505.
91. Manzini, M. C.; Gleason, D.; Chang, B. S.; Hill, R. S.; Barry, B. J.; Partlow, J. N.; et al. (2008). Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WW outside of the Middle East. Human Mutation, 29, E231-E241.
92. Manzini, M. C.; Tambunan, D. E.; Hill, R. S.; Yu, T. W.; Maynard, T. M.; Heinzen, E. L.; et al. (2012). Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg Syndrome. American Journal of Human Genetics, 91, 541-547.
93. McWhorter, M. L.; Monani, U. R.; Burghes, A. H.; & Beattie, C. E. (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. Journal of Cell Biology, 162, 919-931.
94. Milone, M.; Wang, H. L.; Ohno, K.; Fukudome, T.; Pruitt, J. N.; Bren, N.; et al. (1997). Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. Journal of Neuroscience, 17, 5651-5665.
95. Miner, J. H.; & Yurchenco, P. D. (2004). Laminin functions in tissue morphogenesis. Annual Review of Cell and Developmental Biology, 20, 255-284.
96. Moore, C. J.; Tse Goh, H.; & Hewitt, J. E. (2008). Genes required for functional glycosylation of dystroglycan are conserved in zebrafish. Genomics, 92, 159-167.
97. Moscou, M. J.; & Bogdanove, A. J. (2009). A simple cipher governs DNA recognition by TAL effectors. Science, 326, 1501.
98. Müller, J. S.; Herczegfalvi, A.; Vilchez, J. J.; Colomer, J.; Bachinski, L. L.; Mihaylova, V.; et al. (2007). Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain, 130, 1497-1506.
99. Müller, J. S.; Jepson, C. D.; Laval, S. H.; Bushby, K.; Straub, V.; & Lochmüller, H. (2010). Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes. Human Molecular Genetics, 19, 1726-1740.
100. Neubig, R. R.; Krodel, E. K.; Boyd, N. D.; & Cohen, J. B. (1979). Acetylcholine and local anesthetic binding to Torpedo nicotinic postsynaptic membranes after removal of nonreceptor peptides. Proceedings of the National Academy of Sciences of the United States of America, 76, 690-694.
101. Neuromuscular disorders: Gene location. (2006). Neuromuscular Disorders, 16, 64-90.
102. Ng, S. B.; Buckingham, K. J.; Lee, C.; Bigham, A. W.; Tabor, H. K.; Dent, K. M.; et al. (2010). Exome sequencing identifies the cause of a Mendelian disorder. Nature Genetics, 42, 30-35.
103. Nigro, V.; Aurino, S.; & Piluso, G. (2011). Limb girdle muscular dystrophies: Update on genetic diagnosis and therapeutic approaches. Current Opinion in Neurology, 5, 429-436.
104. Nigro, V.; Moreira, E.d. S.; Piluso, G.; Vainzof, M.; Belsito, A.; Politano, L.; et al. (1996). Autosomal recessive limb girdle muscular dystrophy (LGMD2F) is caused by a mutation in the delta-sarcoglycan gene. Nature Genetics, 14, 195-198.
105. Noakes, P. G.; Phillips, W. D.; Hanley, T. A.; Sanes, J. R.; & Merlie, J. P. (1993). 43 K protein and acetylcholine receptors colocalize during the initial stages of neuromuscular synapse formation in vivo. Developmental Biology, 155, 275-280.
106. Norwood, F. L.; Harling, C.; Chinnery, P. F.; Eagle, M.; Bushby, K.; & Straub, V. (2009). Prevalence of genetic muscle disease in Northern England: In-depth analysis of a muscle clinic population. Brain, 132, 3175-3186.
107. Ohno, K. (2013) Glycosylation defects as an emerging novel cause leading to a limb-girdle type of congenital myasthenic syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, [Epub ahead of print], PMID: 23457230.
108. Okada, K.; Inoue, A.; Okada, M.; Murata, Y.; Kakuta, S.; Jigami, T.; et al. (2006). The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science, 312, 1802-1805.
109. Ono, F.; Shcherbatko, A.; Higashijima, S. I.; Mandel, G.; & Brehm, P. (2002). The zebrafish motility mutant twitch once reveals new roles for rapsyn in synaptic function. Journal of Neuroscience, 22, 6491-6498.
110. Oprea, G. E.; Krober, S.; McWhorter, M. L.; Rossoll, W.; Muller, S.; Krawczak, M.; et al. (2008). Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science, 320, 524-527.
111. Qin, J.; Diaz-Cueto, L.; Schwarze, J. E.; Takahashi, Y.; Imai, M.; Isuzugawa, K.; et al. (2005). Effects of progranulin on blastocyst hatching and subsequent adhesion and outgrowth in the mouse. Biology of Reproduction, 73, 434-442.
112. Ramesh, T.; Lyon, A. N.; Pineda, R. H.; Wang, C.; Janssen, P. M. L.; Canan, B. D.; et al. (2010). A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Disease Models and Mechanisms, 3, 652-662.
113. Reyon, D.; Tsai, S. Q.; Khayter, C.; Foden, J. A.; Sander, J. D.; & Joung, J. K. (2012). FLASH assembly of TALENs for high throughput genome editing. Nature Biotechnology, 30, 460-465.
114. Rochette, C. F.; Gilbert, N.; & Simard, L. R. (2001). SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Human Genetics, 108, 255-266.
115. Roostalu, U.; & Strähle, U. (2012). In vivo imaging of molecular interactions at damaged sarcolemma. Developmental Cell, 22, 515-529.
116. Roscioli, T.; Kamsteeg, E. J.; Buysse, K.; Maystadt, I.; van Reeuwijk, J.; van den Elzen, C.; et al. (2012). Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan. Nature Genetics, 44, 581-585.
117. Sánchez-Ramos, C.; Guerrera, M. C.; Bonnin-Arias, C.; Calavia, M. G.; Laurà, R.; Germanà, A.; et al. (2012). Expression of TRPV4 in the zebrafish retina during development. Microscopy Research and Technique, 75, 743-748.
118. Sander, J. D.; Cade, L.; Khayter, C.; Reyon, D.; Peterson, R. T.; Joung, J. K.; et al. (2011). Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nature Biotechnology, 29, 697-698.
119. Santoriello, C.; & Zon, L. I. (2012). Hooked! Modeling human disease in zebrafish. Journal of Clinical Investigation, 122, 2337-2343.
120. Sewry, C. A. (2010). Muscular dystrophies: An update on pathology and diagnosis. Acta Neuropathologica, 120, 343-358.
121. Sobel, A.; Weber, M.; & Changeux, J. P. (1977). Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent extracted forms from Torpedo marmorata electric organ. European Journal of Biochemistry, 80, 215-224.
122. Steffen, L. S.; Guyon, J. R.; Vogel, E. D.; Beltre, R.; Pusack, T. J.; Zhou, Y.; et al. (2007). Zebrafish orthologs of human muscular dystrophy genes. BMC Genomics, 20, 8-79.
123. Tan, E.; Topaloglu, H.; Sewry, C.; Zorlu, Y.; Naom, I.; Erdem, S.; et al. (1997). Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscular Disorders, 7, 85-89.
124. Tesson, L.; Usal, C.; Ménoret, S.; Leung, E.; Niles, B. J.; Remy, S.; et al. (2011). Knockout rats generated by embryo microinjection of TALENs. Nature Biotechnology, 29, 695-696.
125. Thornhill, P.; Bassett, D.; Lochmüller, H.; Bushby, K.; & Straub, V. (2008). Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP). Brain, 131, 1551-1561.
126. Tunggal, P.; Smyth, N.; Paulsson, M.; & Ott, M. C. (2000). Laminins: Structure and genetic regulation. Microscopy Research and Technique, 51, 214-227.
127. van Reeuwijk, J.; van den Janssen, M.; Elzen, C.; Beltran-Valero de Bernabé, D.; Sabatelli, P.; Merlini, L.; et al. (2005). POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. Journal of Medical Genetics, 42, 907-912.
128. Vasli, N.; Böhm, J.; Le Gras, S.; Muller, J.; Pizot, C.; Jost, B.; et al. (2012). Next generation sequencing for molecular diagnosis of neuromuscular diseases. Acta Neuropathologica, 124, 273-283.
129. Verhaert, D.; Richards, K.; Rafael-Fortney, J. A.; & Raman, S. V. (2011). Cardiac involvement in patients with muscular dystrophies: Magnetic resonance imaging phenotype and genotypic considerations. Circulation. Cardiovascular Imaging, 4, 67-76.
130. Verma, P.; Kumar, A.; & Goswami, C. (2010). TRPV4-mediated channelopathies. Channels, 4, 319-328.
131. Walogorsky, M.; Mongeon, R.; Wen, H.; Mandel, G.; & Brehm, P. (2012a). Acetylcholine receptor gating in a zebrafish model for slow-channel syndrome. Journal of Neuroscience, 32, 7941-7948.
132. Walogorsky, M.; Mongeon, R.; Wen, H.; Nelson, N. R.; Urban, J. M.; Ono, F.; et al. (2012b). Zebrafish model for congenital myasthenic syndrome reveals mechanisms causal to developmental recovery. Proceedings of the National Academy of Sciences of the United States of America, 109, 17711-17716.
133. Walton, J. N. (1981). Disorders of voluntary muscle (4th ed.). Churchill Livingston: New York.
134. Yoshida, A.; Kobayashi, K.; Manya, H.; Taniguchi, K.; Kano, H.; Mizuno, M.; et al. (2001). Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Developmental Cell, 1, 717-724.
135. Zhang, R.; Yang, J.; Zhu, J.; & Xu, X. (2009). Depletion of zebrafish Tcap leads to muscular dystrophy via disrupting sarcomere-membrane interaction, not sarcomere assembly. Human Molecular Genetics, 18, 4130-4140.
136. Zhou, J.; Tawk, M.; Tiziano, F. D.; Veillet, J.; Bayes, M.; Nolent, F.; et al. (2012). Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. American Journal of Human Genetics, 91, 5-14.
137. Zhu, J.; Nathan, C.; Jin, W.; Sim, D.; Ashcroft, G. S.; Wahl, S. M.; et al. (2002). Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair. Cell, 111, 867-878.
138. Zon, L. I.; & Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nature Reviews. Drug Discovery, 4, 35-44.